Mechanism of action
Pioglitazone decreases insulin resistance in the periphery and in the liver resulting in increased insulin dependent glucose disposal and decreased hepatic gluconeogenesis. It activates the nuclear peroxisome proliferator activated receptor-gamma (PPAR-gamma), which leads to the increased transcription of a number of insulin responsive genes involved in the control of glucose and lipid metabolism.